Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature

Insights

Host-microbe interactions in the ileum are key to Crohn disease (CD) development. Specific gene expression and microbial profiles in the ileum predict disease and potential treatment responses in pediatric patients.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Genomics

Background:

  • Gut microbial community interactions are implicated in Crohn disease (CD) pathogenesis.
  • Direct evidence linking host-microbe interactions to early CD onset is limited.

Purpose of the Study:

  • To characterize ileal gene expression and microbial communities in treatment-naive pediatric patients with CD, ulcerative colitis (UC), and controls.
  • To identify host-microbe signatures specific to CD at the disease's onset.

Main Methods:

  • Global ileal gene expression profiling.
  • Ileal microbial community analysis (16S rRNA sequencing).
  • Analysis of 359 treatment-naive pediatric patients (CD, UC, controls).

Main Results:

  • Identified core ileal gene expression and microbial profiles specific to CD, independent of clinical inflammation.
  • Observed increased dual oxidase (DUOX2) expression and Proteobacteria expansion in both UC and CD.
  • Found downregulated apolipoprotein A1 (APOA1) gene expression linked to CD-specific Firmicutes alterations.
  • CD-specific signatures correlated with oxidative stress, Th1 polarization, and mucosal injury severity.
  • A model including APOA1 and microbial abundance predicted remission more accurately than clinical factors alone.

Conclusions:

  • The ileum is the primary site for the induction of all forms of CD.
  • CD-specific host-microbe profiles offer prognostic and therapeutic potential.
  • Host-microbe interactions at disease onset are crucial for understanding CD pathogenesis.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
29
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
34
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K